The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Inflammation in Atherosclerosis
Open accessAbstract
Experimental work has elucidated molecular and cellular pathways of inflammation that promote atherosclerosis. Unraveling the roles of cytokines as inflammatory messengers provided a mechanism whereby risk factors for atherosclerosis can alter arterial biology, and produce a systemic milieu that favors atherothrombotic events. The discovery of the immune basis of allograft arteriosclerosis demonstrated that inflammation per se can drive arterial hyperplasia, even in the absence of traditional risk factors. Inflammation regulates aspects of plaque biology that trigger the thrombotic complications of atherosclerosis. Translation of these discoveries to humans has enabled both novel mechanistic insights and practical clinical advances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Self-citationRosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Self-citationInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Self-citationRosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Self-citationGalis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Self-citation
Cited by
Items 201–283 of 283
Accelerated atherosclerosis in patients with SLE—mechanisms and management
Skaggs, B. J., Hahn, B. H., & McMahon, M. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.14 · Cited by 253
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Chan, J. M., Zhang, L., Tong, R., Ghosh, D., Gao, W., Liao, G., Yuet, K. P., Gray, D., Rhee, J.-W., Cheng, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914585107 · Cited by 253
Self-citationSleep duration, cardiovascular disease, and proinflammatory biomarkers
Grandner, M., Sands-Lincoln, Pak, & Garland (2013) · Nature and Science of Sleep · doi:10.2147/nss.s31063 · Cited by 246
Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men
Lampert, R., Bremner, J. D., Su, S., Miller, A., Lee, F., Cheema, F., Goldberg, J., & Vaccarino, V. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.07.009 · Cited by 240
Raiten, D. J., Ashour, F. A. S., Ross, A. C., Meydani, S. N., Dawson, H. D., Stephensen, C. B., Brabin, B. J., Suchdev, P. S., & van Ommen, B. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.194571 · Cited by 234
Anti-inflammatory effects of Rhodiola rosea L.: A review
Pu, W.-L., Zhang, M.-Y., Bai, R.-Y., Sun, L.-K., Li, W.-H., Yu, Y.-L., Zhang, Y., Song, L., Wang, Z.-X., Peng, Y.-F., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109552 · Cited by 227
Gola, H., Engler, H., Sommershof, A., Adenauer, H., Kolassa, S., Schedlowski, M., Groettrup, M., Elbert, T., & Kolassa, I.-T. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-40 · Cited by 225
The GAIT system: a gatekeeper of inflammatory gene expression
Mukhopadhyay, R., Jia, J., Arif, A., Ray, P. S., & Fox, P. L. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.03.004 · Cited by 216
Adipose Tissue-Derived Omentin-1 Function and Regulation
Watanabe, T., Watanabe‐Kominato, K., Takahashi, Y., Kojima, M., & Watanabe, R. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160043 · Cited by 210
“Heart failure 305 (35-473) ↓ 494 (35-630) P = 0.”
Hasturk, H., Abdallah, R., Kantarci, A., Nguyen, D., Giordano, N., Hamilton, J., & Van Dyke, T. E. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305324 · Cited by 199
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
Stein, S., Lohmann, C., Schäfer, N., Hofmann, J., Rohrer, L., Besler, C., Rothgiesser, K. M., Becher, B., Hottiger, M. O., Borén, J., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq107 · Cited by 188
Holmes, M. V., Richardson, T. G., Ference, B. A., Davies, N. M., & Davey Smith, G. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00493-1 · Cited by 184
Zimmerman, B., Rypma, B., Gratton, G., & Fabiani, M. (2021) · Psychophysiology · doi:10.1111/psyp.13796 · Cited by 179
Paul, A., Chang, B. H.-J., Li, L., Yechoor, V. K., & Chan, L. (2008) · Circulation Research · doi:10.1161/circresaha.107.168070 · Cited by 171
The overtraining syndrome in athletes: A stress-related disorder
Angeli, A., Minetto, M., Dovio, A., & Paccotti, P. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347487 · Cited by 169
(2010) · PubMed Central · Cited by 169
Hostinar, C. E., Lachman, M. E., Mroczek, D. K., Seeman, T. E., & Miller, G. E. (2015) · Developmental Psychology · doi:10.1037/dev0000049 · Cited by 167
PPARδ as a therapeutic target in metabolic disease
Reilly, S. M., & Lee, C.-H. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.040 · Cited by 164
“Macrophage derived foam cells are a major component of atherosclerotic lesions [29,30].”
BackgroundCardiovascular organ-on-a-chip platforms for drug discovery and development
Ribas, J., Sadeghi, H., Manbachi, A., Leijten, J., Brinegar, K., Zhang, Y. S., Ferreira, L., & Khademhosseini, A. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0002 · Cited by 161
“CVDs also include diseases affecting the general vasculature, such as atherosclerosis, hypertension, and other vascular cell dysfunctions that can result in occlusion and thrombosis.(2,3) Over the years, these cardiovascular complications have been treated with numerous interventional(4) and pharmacological agents.”
BackgroundLow, A. S. L., Symmons, D. P. M., Lunt, M., Mercer, L. K., Gale, C. P., Watson, K. D., Dixon, W. G., & Hyrich, K. L. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209784 · Cited by 158
de Roos, B., Mavrommatis, Y., & Brouwer, I. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00189.x · Cited by 151
McCarthy, J. R., Korngold, E., Weissleder, R., & Jaffer, F. A. (2010) · Small · doi:10.1002/smll.201000596 · Cited by 151
Novel antiatherosclerotic therapies
Libby, P., & Everett, B. M. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.310958 · Cited by 145
Self-citationEvidence of proatherogenic inflammation in polycystic ovary syndrome
González, F., Rote, N. S., Minium, J., & Kirwan, J. P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.022 · Cited by 135
Jahagirdar, R., Zhang, H., Azhar, S., Tobin, J., Attwell, S., Yu, R., Wu, J., McLure, K. G., Hansen, H. C., Wagner, G. S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.008 · Cited by 134
Hennuyer, N., Duplan, I., Paquet, C., Vanhoutte, J., Woitrain, E., Touche, V., Colin, S., Vallez, E., Lestavel, S., Lefebvre, P., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.003 · Cited by 132
Preston Mason, R. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0762-1 · Cited by 129
Antonov, A. S., Antonova, G. N., Munn, D. H., Mivechi, N., Lucas, R., Catravas, J. D., & Verin, A. D. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22356 · Cited by 128
Askarpour, M., Khani, D., Sheikhi, A., Ghaedi, E., & Alizadeh, S. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03926-0 · Cited by 120
High TNF-α levels in resting B cells negatively correlate with their response
Frasca, D., Diaz, A., Romero, M., Landin, A. M., & Blomberg, B. B. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.004 · Cited by 115
“…can contribute to the development of agerelated chronic diseases typical of old age, such as Alzheimer's disease (Griffin, 2006), atherosclerosis (Libby, 2002, 2006), osteoporosis (Kimble et al., 1995), type-2 diabetes (Festa et al., 2002; Pradhan et al., 2001), rheumatoid arthritis (Isaacs,…”
Leuschner, F., & Nahrendorf, M. (2011) · Circulation Research · doi:10.1161/circresaha.110.232678 · Cited by 110
Aging-induced biological changes and cardiovascular diseases.
Fajemiroye, J. O., Cunha, L. C. D., Saavedra-Rodríguez, R., Rodrigues, K. L., Naves, L. M., Mourão, A. A., Silva, E. F. D., Williams, N. E. E., Martins, J. L. R., Sousa, R. B., et al. (2018) · BioMed Research International · doi:10.1155/2018/7156435 · Cited by 109
Thorp, E., Subramanian, M., & Tabas, I. (2011) · European Journal of Immunology · doi:10.1002/eji.201141719 · Cited by 107
Prather, A. A., Epel, E. S., Cohen, B. E., Neylan, T. C., & Whooley, M. A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.004 · Cited by 100
“Elevated systemic levels of inflammation contribute to CHD by accelerating the development and progression of atherosclerotic plaques (Libby, 2002; Ross, 1999) and”
BackgroundREES, M. D., HAWKINS, C. L., & DAVIES, M. J. (2004) · Biochemical Journal · doi:10.1042/bj20040148 · Cited by 100
Celastrol-loaded PEG- b -PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis
Allen, S. D., Liu, Y.-G., Kim, T., Bobbala, S., Yi, S., Zhang, X., Choi, J., & Scott, E. A. (2019) · Biomaterials Science · doi:10.1039/c8bm01224e · Cited by 95
Human vascular microphysiological system for in vitro drug screening
Fernandez, C. E., Yen, R. W., Perez, S. M., Bedell, H. W., Povsic, T. J., Reichert, W. M., & Truskey, G. A. (2016) · Scientific Reports · doi:10.1038/srep21579 · Cited by 93
Hostinar, C. E., Nusslock, R., & Miller, G. E. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2016.1266647 · Cited by 90
“1611 Libby, P. (2012). Inflammation in atherosclerosis.”
Frasca, D. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.07.002 · Cited by 82
Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis
Jacinto, T. A., Meireles, G. S., Dias, A. T., Aires, R., Porto, M. L., Gava, A. L., Vasquez, E. C., Pereira, T. M. C., Campagnaro, B. P., & Meyrelles, S. S. (2018) · Biological Research · doi:10.1186/s40659-018-0182-7 · Cited by 86
Fontana, L. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2008.04.005 · Cited by 81
Fialkow, J. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0170-7 · Cited by 80
Myocardial Infarction Triggers Chronic Cardiac Autoimmunity in Type 1 Diabetes
Gottumukkala, R. V. S. R. K., Lv, H., Cornivelli, L., Wagers, A. J., Kwong, R. Y., Bronson, R., Stewart, G. C., Schulze, P. C., Chutkow, W., Wolpert, H. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003551 · Cited by 76
Lee, S.-G., Lee, S.-J., Lee, J.-J., Kim, J.-S., Lee, O.-H., Kim, C.-K., Kim, D., Lee, Y.-H., Oh, J., Park, S., et al. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2019.0296 · Cited by 75
Meng, H., Matthan, N. R., Wu, D., Li, L., Rodríguez-Morató, J., Cohen, R., Galluccio, J. M., Dolnikowski, G. G., & Lichtenstein, A. H. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz095 · Cited by 75
Liu, M., Yu, Y., Jiang, H., Zhang, L., Zhang, P.-P., Yu, P., Jia, J.-G., Chen, R.-Z., Zou, Y.-Z., & Ge, J.-B. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.8 · Cited by 69
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
Luchtefeld, M., Schunkert, H., Stoll, M., Selle, T., Lorier, R., Grote, K., Sagebiel, C., Jagavelu, K., Tietge, U. J. F., Assmus, U., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070120 · Cited by 69
Eating the dead to keep atherosclerosis at bay
Brophy, M. L., Dong, Y., Wu, H., Rahman, H. N. A., Song, K., & Chen, H. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00002 · Cited by 68
Wang, Y. I., Bettaieb, A., Sun, C., DeVerse, J. S., Radecke, C. E., Mathew, S., Edwards, C. M., Haj, F. G., Passerini, A. G., & Simon, S. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078322 · Cited by 65
Bray, J. J. H., Foster-Davies, H., & Stephens, J. W. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108368 · Cited by 64
Lin, J. E., Neylan, T. C., Epel, E., & O’Donovan, A. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.015 · Cited by 63
“Current states may bias such reports and bias our models (Maughan and Rutter, 1997).”
Kunutsor, S. K., Kurl, S., Zaccardi, F., & Laukkanen, J. A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.020 · Cited by 58
Bras, J. P., Silva, A. M., Calin, G. A., Barbosa, M. A., Santos, S. G., & Almeida, M. I. (2017) · PLOS ONE · doi:10.1371/journal.pone.0188530 · Cited by 58
Thrombosis-on-a-chip: prospective impact of microphysiological models of vascular thrombosis
Pandian, N. K. R., Mannino, R. G., Lam, W. A., & Jain, A. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.12.001 · Cited by 56
Jager, N. A., Wallis de Vries, B. M., Hillebrands, J.-L., Harlaar, N. J., Tio, R. A., Slart, R. H. J. A., van Dam, G. M., Boersma, H. H., Zeebregts, C. J., & Westra, J. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0882-0 · Cited by 55
Monocyte Subset Dynamics in Human Atherosclerosis Can Be Profiled with Magnetic Nano-Sensors
Wildgruber, M., Lee, H., Chudnovskiy, A., Yoon, T.-J., Etzrodt, M., Pittet, M. J., Nahrendorf, M., Croce, K., Libby, P., Weissleder, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005663 · Cited by 54
Self-citationLee, S. A., Kim, H. J., Chang, K. C., Baek, J. C., Park, J. K., Shin, J. K., Choi, W. J., Lee, J. H., & Paik, W. Y. (2009) · The Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2009.13.4.301 · Cited by 53
Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
Abdo, A. I., Rayner, B. S., van Reyk, D. M., & Hawkins, C. L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.08.004 · Cited by 51
Digoxin reduces atherosclerosis in apolipoprotein E‐deficient mice
Shi, H., Mao, X., Zhong, Y., Liu, Y., Zhao, X., Yu, K., Zhu, R., Wei, Y., Zhu, J., Sun, H., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13453 · Cited by 49
Circulating adhesion molecules in obstructive sleep apnea and cardiovascular disease
Pak, V. M., Grandner, M. A., & Pack, A. I. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2013.01.002 · Cited by 43
Zeigler, C. C., Wondimu, B., Marcus, C., & Modéer, T. (2015) · BMC Oral Health · doi:10.1186/s12903-015-0026-6 · Cited by 41
Zhou, D., Wang, G., Fan, Y., Wan, Z., & Liu, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3993 · Cited by 40
Di Marco, E., Gray, S. P., Chew, P., Kennedy, K., Cooper, M. E., Schmidt, H. H. H. W., & Jandeleit-Dahm, K. A. M. (2016) · Clinical Science · doi:10.1042/cs20160249 · Cited by 37
Muzurović, E., & Mikhailidis, D. P. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1795132 · Cited by 35
Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence
Sherratt, S. C. R., Lero, M., & Mason, R. P. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000665 · Cited by 33
Machine learning approaches for biomarker discovery to predict large-artery atherosclerosis
Sun, T.-H., Wang, C.-C., Wu, Y.-L., Hsu, K.-C., & Lee, T.-H. (2023) · Scientific Reports · doi:10.1038/s41598-023-42338-0 · Cited by 32
Chukkapalli, S. S., Ambadapadi, S., Varkoly, K., Jiron, J., Aguirre, J. I., Bhattacharyya, I., Morel, L. M., Lucas, A. R., & Lakshmyya, K. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty076 · Cited by 30
The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis
Sallam, T., Ito, A., Rong, X., Kim, J., van Stijn, C., Chamberlain, B. T., Jung, M. E., Chao, L. C., Jones, M., Gilliland, T., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047548 · Cited by 30
Meyer, J. D., Hayney, M. S., Coe, C. L., Ninos, C. L., & Barrett, B. P. (2019) · Journal of Sport and Exercise Psychology · doi:10.1123/jsep.2018-0214 · Cited by 29
“Elevated inflammatory indicators are associated with both physiological and psychological disturbance, including chronic stress (Libby, 2002, 2007; Miller, Maletic, & Raison, 2009; Rosenkranz, 2007; Wellen & Hotamisligil, 2005).”
BackgroundElevated monocyte-to-HDL cholesterol ratio predicts post-stroke depression
Li, Y., Zhang, M., Xue, M., Liu, D., & Sun, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.902022 · Cited by 27
New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Farokhi, S., Razavi, Z.-S., Mavaei, M., Shadab, A., Afkhami, H., & Sardarabadi, H. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-06113-8 · Cited by 27
Nagasawa, S.-Y., Ohkubo, T., Masaki, K., Barinas-Mitchell, E., Miura, K., Seto, T., El-Saed, A., Kadowaki, T., Willcox, B. J., Edmundowicz, D., et al. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.23580 · Cited by 26
RLIP76 protein knockdown attenuates obesity due to a high-fat diet
Singhal, S. S., Figarola, J., Singhal, J., Reddy, M. A., Liu, X., Berz, D., Natarajan, R., & Awasthi, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.480194 · Cited by 26
“MetS characterized by hyperlipidemia, low high-density lipoprotein (HDL) cholesterol, high blood pressure, and high fasting glucose frequently coexists with obesity (26, 27).”
BackgroundShin, Y., Lim, S., Kim, J., Jeon, J. S., Yoo, H., & Gweon, B. (2019) · Lab on a Chip · doi:10.1039/c9lc00352e · Cited by 26
Imaging macrophage development and fate in atherosclerosis and myocardial infarction
Swirski, F. K., & Nahrendorf, M. (2013) · Immunology & Cell Biology · doi:10.1038/icb.2012.72 · Cited by 23
Endocytic Adaptors in Cardiovascular Disease
Cui, K., Dong, Y., Wang, B., Cowan, D. B., Chan, S.-L., Shyy, J., & Chen, H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.624159 · Cited by 23
Koyama, S., Horie, T., Nishino, T., Baba, O., Sowa, N., Miyasaka, Y., Kuwabara, Y., Nakao, T., Nishiga, M., Nishi, H., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012609 · Cited by 23
Migraine without aura and subclinical atherosclerosis in young females: Is gut microbiota to blame?
Georgescu, D., Iurciuc, M. S., Ionita, I., Dragan, S., Muntean, M., Ancusa, O. E., Reisz, D., Ionita, M., & Lighezan, D. (2019) · Medicina · doi:10.3390/medicina55120786 · Cited by 19
Macer-Wright, J. L., Stanley, N. R., Portman, N., Tan, J. T., Bursill, C., Rayner, B. S., & Hawkins, C. L. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00044 · Cited by 18
Shaaban, D., & Al-Mutairi, N. (2018) · Journal of Dermatological Treatment · doi:10.1080/09546634.2016.1254145 · Cited by 18
Tranfield, E. M., van Eeden, S. F., Yatera, K., Hogg, J. C., & Walker, D. C. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70422-0 · Cited by 15
“Without an ECM foundation, the stability and integrity of the endothelial layer are compromised, resulting in this layer becoming a contributor to atherosclerotic plaque instability, and a possible precursor to plaque rupture and acute cardiovascular events (44,45).”
BackgroundLindsay, E. K. (2021) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2021.100338 · Cited by 10
Zhang, L., Altemus, J., Ding, L., Cherepanova, O., Byzova, T. V., & Podrez, E. A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105425 · Cited by 1
Metadata
- Authors
- Libby, P.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2012-09
- Volume
- 32
- Issue
- 9
- Pages
- 2045-2051
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2156593520
- Cited by
- 3,736
- References
- 101
- FWCI
- 110.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.